A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, which plaintiffs allege increases risk of thigh bone fractures, according to court documents reviewed by Becker’s.
From the FTC suing the nation’s three largest pharmacy benefit managers to Epic facing an antitrust lawsuit, here are 10 healthcare industry lawsuits, settlements and legal developments that Becker’s has reported since Sept. 13:
California Gov. Gavin Newsom signed a new law Sept. 20 that prohibits social media platforms from delivering addictive feeds to children beginning in 2027, unless the platform has verified that the user is not a minor or has obtained verifiable parenta…
After weeks of internal disagreements at the Federal Trade Commission about pharmacy benefit managers, the agency said Sept. 20 that it is suing CVS Caremark, Optum Rx and Express Scripts over allegedly inflating insulin prices.
The Equal Employment Opportunity Commission has filed a lawsuit in federal court alleging that Northwest Medical Center-Bentonville (Ark.) refused to allow an employee to perform his surgical technician job duties because of his sex.
From Walgreens agreeing to pay more than $100 million to settle false claims allegations, to a physician indicted in an alleged $32.7 million Medicare scheme, here are 10 healthcare billing fraud cases Becker’s has reported since Sept. 10:
A liver transplant surgeon at Memorial Hermann-Texas Medical Center frequently altered patients’ records in a national database, potentially preventing them from receiving transplants, according to CMS documents obtained by the Houston Chronicle.
Cardiology practice Oregon Health Center has filed a lawsuit against Salem (Ore.) Health, accusing the health system of defamation and monopolizing the cardiology market, according to local reports.
The Senate Committee on Health, Education, Labor and Pensions voted Sept. 19 to forward two resolutions regarding contempt charges against Steward Health Care chairman and CEO Ralph de la Torre, MD, to the full Senate.